Sandoz announces changes in the Board of Directors
01 Februar 2024 - 7:15AM
UK Regulatory
Sandoz announces changes in the Board of Directors
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange
Listing Rules
MEDIA RELEASE
- Graeme Pitkethly nominated as candidate for election to the
Sandoz Board of Directors at the upcoming Annual General
Meeting
- François-Xavier Roger announced to pursue a new executive
responsibility and therefore to step down from the Sandoz Board of
Directors post publication of the financial statements 2023
Basel, February 1, 2024 - The Board of
Directors of Sandoz announced today that it proposes Graeme
Pitkethly for election to its Board of Directors at the company’s
next Annual General Meeting on April 30, 2024.
If elected by the shareholders at the upcoming Annual General
Meeting, the Board intends to appoint Graeme Pitkethly as Chair of
its Audit, Risk and Compliance Committee. In this role Graeme will
succeed François-Xavier Roger, who decided to step down at the end
of March 2024 as a member of the Board of Directors as he has
accepted a new executive role. François-Xavier Roger has been a
Sandoz Board member and Chair of the Audit, Risk and Compliance
Committee since August 2023. His resignation will be effective
March 31, 2024, post publication of the Sandoz 2023 financial
statements.
The Board of Directors further intends to appoint Gilbert
Ghostine, Chairman, as ad interim member and Chair of the Audit,
Risk and Compliance Committee for the interim period from April 1,
2024, to the date of the Annual General Meeting on April 30,
2024.
Gilbert Ghostine, Chairman of Sandoz, said: "I would like to
express my heartfelt gratitude to François-Xavier. His contribution
and thoughtful guidance have been instrumental in Sandoz’s first
year as a standalone publicly traded company. We are thankful for
his valued input and wish François-Xavier every success in his new
endeavour. At the same time, I am extremely pleased that we can
propose an exceptional candidate to our shareholders. Graeme has an
outstanding track record in finance and strategic planning, which
includes helping to build one of the world's most valuable
companies."
Graeme Pitkethly (1966) was Chief Financial Officer and a Board
member of Unilever plc until December 2023. He joined Unilever in
2002 and, prior to his appointment as the CFO, was responsible for
its UK and Ireland business. He also held a number of senior
financial and commercial roles within Unilever and spent the earlier
part of his career in senior corporate finance roles in the
telecommunications industry. Graeme served as Vice President of
Financial Planning and Vice President of Corporate Development at
FLAG Telecom and started his career at PricewaterhouseCoopers.
Graeme serves as a member of the Board of Directors of Pearson plc
since 2019 and chairs the Audit Committee. He is a Trustee of the
Leverhulme Trust and serves as the Vice Chair of the Task Force on
Climate-Related Financial Disclosures. Graeme is a Chartered
Accountant, with a bachelor’s degree in applied chemistry from
Strathclyde University.
About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and
biosimilar medicines, with a growth strategy driven by its Purpose:
pioneering access for patients. 22,000 people of more than 100
nationalities work together to bring Sandoz medicines to some 500
million patients worldwide, generating substantial global
healthcare savings and an even larger total social impact. Its
leading portfolio of more than 1500 products addresses diseases
from the common cold to cancer. Headquartered in Basel,
Switzerland, Sandoz traces its heritage back to the year 1886. Its
history of breakthroughs includes Calcium Sandoz in 1929, the
world’s first oral penicillin in 1951, and the first biosimilar in
2006. In 2022, Sandoz achieved sales of USD 9.1 billion and core
EBITDA of USD 1.9 billion.
Disclaimer
This Media Release contains forward-looking statements, which offer
no guarantee with regard to future performance. These statements
are made on the basis of management’s views and assumptions
regarding future events and business performance at the time the
statements are made. They are subject to risks and uncertainties
including, but not confined to, future global economic conditions,
exchange rates, legal provisions, market conditions, activities by
competitors and other factors outside of the control of Sandoz.
Should one or more of these risks or uncertainties materialize or
should underlying assumptions prove incorrect, actual outcomes may
vary materially from those forecasted or expected. Each
forward-looking statement speaks only as of the date of the
particular statement, and Sandoz undertakes no obligation to
publicly update or revise any forward-looking statements, except as
required by law.
CONTACTS
Global Media Relations contacts |
Investor Relations contacts |
Global.MediaRelations@sandoz.com |
Investor.Relations@sandoz.com |
Joerg
E. Allgaeuer
+49 171 838 4838 |
Karen M. King
+1 609 722 0982 |
Chris
Lewis
+49 174 244 9501 |
Laurent de Weck
+41 61 529 14 85 |
- Sandoz Board Change FR+GP Media Release
Sandoz (LSE:0SAN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Sandoz (LSE:0SAN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024